ŠTOURAČ, Petr, Milan ADAMUS, Dagmar SEIDLOVÁ, Tomáš PAVLÍK, Petr JANKŮ, Ivo KŘIKAVA, Zdenek MROZEK, Martin PROCHÁZKA, Jozef KLUČKA, Roman ŠTOUDEK, Ivana BÁRTÍKOVÁ, Martina KOSINOVÁ, Hana HARAZIM, Hana ROBOTKOVÁ, Karel HEJDUK, Zuzana HODICKÁ, Martina KIRCHNEROVA, Jana FRANČÁKOVÁ, Lenka OBARE PYSZKOVA, Jarmila HLOZKOVA and Pavel ŠEVČÍK. Low-dose or high-dose rocuronium reversed with neostigmine or sugammadex for cesarean delivery anesthesia: A randomized controlled non-inferiority trial of time to tracheal intubation and extubation. Anesthesia and Analgesia. Philadelphia: Lippincott Williams & Wilkins, 2016, vol. 122, No 5, p. 1536-1545. ISSN 0003-2999. Available from: https://dx.doi.org/10.1213/ANE.0000000000001197.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Low-dose or high-dose rocuronium reversed with neostigmine or sugammadex for cesarean delivery anesthesia: A randomized controlled non-inferiority trial of time to tracheal intubation and extubation.
Name in Czech Nízko nebo vysokodávkované rokuronium zvrácené neostigminem či sugammadexem pro anestezii u císařského řezu: randomizovaná non-inferioritní studie časů tracheální intubace a extubace
Authors ŠTOURAČ, Petr (203 Czech Republic, guarantor, belonging to the institution), Milan ADAMUS (203 Czech Republic), Dagmar SEIDLOVÁ (203 Czech Republic, belonging to the institution), Tomáš PAVLÍK (203 Czech Republic, belonging to the institution), Petr JANKŮ (203 Czech Republic, belonging to the institution), Ivo KŘIKAVA (203 Czech Republic, belonging to the institution), Zdenek MROZEK (203 Czech Republic), Martin PROCHÁZKA (203 Czech Republic), Jozef KLUČKA (703 Slovakia, belonging to the institution), Roman ŠTOUDEK (203 Czech Republic, belonging to the institution), Ivana BÁRTÍKOVÁ (203 Czech Republic), Martina KOSINOVÁ (203 Czech Republic, belonging to the institution), Hana HARAZIM (703 Slovakia, belonging to the institution), Hana ROBOTKOVÁ (203 Czech Republic), Karel HEJDUK (203 Czech Republic, belonging to the institution), Zuzana HODICKÁ (203 Czech Republic, belonging to the institution), Martina KIRCHNEROVA (203 Czech Republic), Jana FRANČÁKOVÁ (203 Czech Republic), Lenka OBARE PYSZKOVA (203 Czech Republic), Jarmila HLOZKOVA (203 Czech Republic) and Pavel ŠEVČÍK (203 Czech Republic).
Edition Anesthesia and Analgesia, Philadelphia, Lippincott Williams & Wilkins, 2016, 0003-2999.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 4.014
RIV identification code RIV/00216224:14110/16:00089761
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1213/ANE.0000000000001197
UT WoS 000374664400046
Keywords (in Czech) císařský řez; aktivní reverze nervosvalové blokády; intubační podmínky; pooperační komplikace
Keywords in English cesarean delivery; active reversla of neuromuscular blockade; intubation conditions; postoperative complications
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 4/8/2016 10:19.
Abstract
BACKGROUND: Rocuronium for cesarean delivery under general anesthesia is an alternative to succinylcholine for rapid-sequence induction of anesthesia because of the availability of sugammadex for reversal of neuromuscular blockade. However, there are no large well-controlled studies in women undergoing general anesthesia for cesarean delivery. The aim of this noninferiority trial was to determine whether rocuronium and sugammadex confer benefit in time to tracheal intubation (primary outcome) and other neuromuscular blockade outcomes compared with succinylcholine, rocuronium, and neostigmine in women undergoing general anesthesia for cesarean delivery. RESULTS: We enrolled 240 parturients. The mean time to tracheal intubation was 2.9 seconds longer in the ROC group (95% confidence interval, -5.3 to 11.2 seconds), noninferior compared with the SUX group. Absence of laryngoscopy resistance was greater in the ROC than in the SUX groups (ROC, 87.5%; SUX, 74.2%; P = 0.019), but there were no differences in vocal cord position (P = 0.45) or intubation response (P = 0.31) between groups. No statistically significant differences in incidence of anesthesia complications or in neonatal outcome were found (10 minute Apgar score, P = 0.07; umbilical artery pH, P = 0.43). The incidence of postpartum myalgia was greater in the SUX group (ROC 0%; SUX 6.7%; P = 0.007). The incidence of subjective complaints was lower in the ROC group (ROC, 21.4%; SUX, 37.5%; P = 0.007). CONCLUSIONS: We conclude that rocuronium for rapid-sequence induction is noninferior for time to tracheal intubation and is accompanied by more frequent absence of laryngoscopy resistance and lower incidence of myalgia in comparison with succinylcholine for cesarean delivery under general anesthesia.
Abstract (in Czech)
Cíl: Rokuronium je alternativou k sukcinylcholinu pro celkovou anestezii u císařského řezu v rámci bleskového úvodu díky dostupnosti sguammadexu. Přesto neexistují velké randomizované studie. Cílem této noninferioritní studie bylo zjistit, zda rokuronium v kombinaci se sugammadexem přináší nějaký benefit oproti sukcinylcholinu. Závěr: Rokuronium pro bleskový úvod je noninferioritní a současně přináší nižší výskyt rezistence k laryngoskopii a nižší výskyt myalgie v porovnání se sukcinylcholinem.
PrintDisplayed: 14/9/2024 08:53